# Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting
Canonical URL: https://biopharmsignal.com/news/HRMY/harmony-biosciences-announces-poster-presentations-at-2026-sleep-annual-meeting
Ticker: HRMY
Company: Harmony Biosciences
Source: Harmony Biosciences
Published: 2026-06-25 13:46 EST
Original Source URL: https://ir.harmonybiosciences.com
## Summary

PLYMOUTH MEETING, Pa. --(BUSINESS WIRE)--Jun. 11, 2026-- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that six abstracts in narcolepsy and idiopathic hypersomnia have been accepted for poster presentation at SLEEP 2026, the 40th annual meeting of the Associated Professional

## Article Body
PLYMOUTH MEETING, Pa. --(BUSINESS WIRE)--Jun. 11, 2026-- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that six abstracts in narcolepsy and idiopathic hypersomnia have been accepted for poster presentation at SLEEP 2026, the 40th annual meeting of the Associated Professional
## Recent Company News
- 2026-06-25 13:46 EST — [Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting](https://biopharmsignal.com/news/HRMY/harmony-biosciences-announces-poster-presentations-at-2026-sleep-annual-meeting) — Source: Harmony Biosciences
- 2026-06-25 13:46 EST — [Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities](https://biopharmsignal.com/news/HRMY/harmony-biosciences-reports-q1-financial-results-and-confirms-2026-net-revenue-guidance-of-over-1-billion-reinforces-2026-strategic-priorities) — Source: Harmony Biosciences
- 2026-06-25 13:46 EST — [Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation](https://biopharmsignal.com/news/HRMY/harmony-biosciences-guides-to-over-1-billion-in-wakixr-revenue-in-2026-advancing-robust-late-stage-pipeline-with-potential-for-long-term-value-creation) — Source: Harmony Biosciences
- 2026-06-25 13:46 EST — [Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026](https://biopharmsignal.com/news/HRMY/harmony-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-24-2026) — Source: Harmony Biosciences
- 2026-06-25 13:46 EST — [Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy](https://biopharmsignal.com/news/HRMY/harmony-biosciences-receives-u-s-food-and-drug-administration-approval-for-wakixr-pitolisant-for-the-treatment-of-cataplexy-in-pediatric-narcolepsy) — Source: Harmony Biosciences
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)